Voreloxin hydrochloride
CAS No. 175519-16-1
Voreloxin hydrochloride ( Vosaroxin | SNS-595 hydrochloride )
产品货号. M23789 CAS No. 175519-16-1
Voreloxin Hydrochloride 是一种有效的拓扑异构酶 II 抑制剂,具有广谱抗肿瘤活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥568 | 有现货 |
|
| 10MG | ¥939 | 有现货 |
|
| 25MG | ¥1655 | 有现货 |
|
| 50MG | ¥2446 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Voreloxin hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Voreloxin Hydrochloride 是一种有效的拓扑异构酶 II 抑制剂,具有广谱抗肿瘤活性。
-
产品描述Voreloxin hydrochloride is a potent inhibitor of Topoisomerase II with broad-spectrum anti-tumor activity.
-
体外实验Voreloxin Hydrochloride is a first-in-class topoisomerase II poison and inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis. Voreloxin (0.1-20 μM) inhibits topoisomerase II activity and induces site-selective DNA DSB in CCRF-CEM cells. Voreloxin (0.11, 0.33, 1, 3 μM) induces G2 arrest partially through topoisomerase II in A549 lung cancer cell line. Voreloxin cytotoxic activity requires DNA intercalation. However, Voreloxin (1-9 μM) does not generate significant levels of ROS. Voreloxin has potent cytotoxic activity in AML cell lines MV4-11 and HL-60, with IC50s of 95 ± 8 nM and 884 ± 114 nM, respectively. Voreloxin in combination with cytarabine shows additive or synergistic activity in acute leukemia cell lines. Voreloxin is active on the primary acute myeloid leukemia (AML) with a mean LD50 of 2.3 μM. The LD50 for voreloxin in myeloid cell lines NB4 and HL-60 is 0.59 μM ± 0.25 μM. Voreloxin causes accumulation of cells in the S and G2 phases of the cell cycle and acts on topoisomerase II.
-
体内实验Voreloxin (20 mg/kg, i.v.) alone results in 80% reduction in bone marrow cellularity of CD-1 mice by administration one dose every 4 days repeated twice (q4d ×2). voreloxin at 10 mg/kg in combination with cytarabine causes ablation of the marrow, dilation of sinusoids, and infiltration of adipocytes in mice. Voreloxin (20 mg/kg, i.v.) combined with cytarabine causes a reversible decrease in myeloid and lymphoid cells in bone marrow and peripheral blood CD-1 mice. voreloxin (10 mg/kg, q4d ×2) and cytarabine in combination causes reversible neutropenia with a more modest impact on platelets CD-1 mice.
-
同义词Vosaroxin | SNS-595 hydrochloride
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis|Topo II
-
研究领域——
-
适应症——
化学信息
-
CAS Number175519-16-1
-
分子量437.9
-
分子式C18H20ClN5O4S
-
纯度>98% (HPLC)
-
溶解度DMSO:20 mg/ml (45.67 mM)
-
SMILES[H]Cl.O=C(C1=CN(C2=NC=CS2)C3=C(C=CC(N4C[C@H](OC)[C@@H](NC)C4)=N3)C1=O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Tsuzuki Y, et al. J Med Chem. 2004, 47(8), 2097-2109.
产品手册
关联产品
-
Fmoc-D-Cha-OH
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyclohexylpropanoic acid 是一种丙氨酸衍生物。
-
Ponicidin
Ponicidin 是一种从冬凌草中提取的二萜类化合物。 Ponicidin 具有免疫调节、抗炎、抗病毒和抗癌活性。
-
Bisindolylmaleimide ...
Bisindolylmaleimide VIIIacetate 是一种有效的选择性 PKC 抑制剂(对于大鼠脑 PKC,IC50:158 nM)。
021-51111890
购物车()
sales@molnova.cn

